henhaobio
Sign in

bioRxivImmunologyPreprint

Protection of Rhesus Macaque from SARS-Coronavirus challenge by recombinant adenovirus vaccine

Y. Chen, C. Qin, Q. Wei, R. Li, H. Gao, H. Zhu, W. Deng, L. Bao, T. Wei

PDFDOI

Abstract

A recombinant adenovirus vaccine against the SARS Coronavirus (SARS-CoV) was constructed, which contains fragments from the S, N, and Orf8 genes. Rhesus Macaques immunized with the recombinant adenovirus generated antigen-specific humoral and cellular response. Furthermore, the vaccine provided significant protection against subsequent live SARS-CoV challenge. In contrast, three out of four monkeys immunized with placebo suffered severe alveolar damage and pulmonary destruction.

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.